Humana stock outlook positive as Mizuho reiterates outperform rating

Mizuho analysts are doubling down on their confidence in Humana, reaffirming an "outperform" rating for the health insurer’s stock. This suggests they expect Humana to keep delivering strong results, likely due to factors like solid earnings or growth potential in the Medicare Advantage market. Investors watching the healthcare sector might see this as a green light—or at least a reassuring nod.